1999 - Haloperidol

Material & Volume
  • Serum, 1ml
Reference values
Age Sex Pregnant Range Unit
All No 1.0-10.0 therapeutic range
>15 toxic
Clinical Information

Type of drug: Antipsychotic
Metabolism: CYP2D6, CYP3A4, AKR, P-gp(ABCB1)
Half life t½: 12-36h
Steady State: 1 week
TDM: highly recommended/ norm of treatment
Additional informations: Higher concentrations can be tolerated as part of long-term therapy; t½ for haldol decanoate 17 days.

Haloperidol is an anti-psychotic agent and anti-dopamine effective ingredient of the group of neuroleptics and butyrophenones, and is administered for the treatment of psychotic disorders such as schizophrenia, mania, acute- and chronic psychosis bus also against mobility hindrances, chronic pain and nausea. The effects are based on the inhibition of the dopamine receptors (primarily Subtype D2) in the central nervous system. This means, that haloperidol has attentuation effects as well as being weakly antihistaminic and anticholinergic. . Frequent side effects are mobility disruptions, lassitude, blood pressure problems and psychotic complaints.

More information
Product names
Analyses groups
  • Haldol®
Position / Price
Position: 1579.00
Price: CHF 126.00
+ Processing fee:
(per order and per day)
CHF 21.60
  • LC-MS
Executing laboratory
labor team w ag
Blumeneggstrasse 55
9403 Goldach
Execution time
1 day
During opening-hours:
Outside opening-hours: